Home »
QUICK LINKS

Share this page with
a friend or colleague

WFH Global Policy and Access Summit (GPAS)

The third edition of the WFH Global Policy and Access Summit (GPAS) will take place from July 6 to 7, 2023. Join your colleagues to:

  1. Share strategies for sustaining and advancing bleeding disorders care in the fast-changing pandemic world
  2. Promote dialogue and knowledge sharing between national member organizations (NMOs), healthcare providers, and national governments

 

Presentations and discussions during the two-day virtual summit will centre around increasing access to diagnosis, treatment and care for people living with bleeding disorders. The conference will include speakers and participants from local and international partner organizations, national government representatives, healthcare professionals, WFH NMO leaders, and bleeding disorders advocates.

The WFH Global Policy and Access Summit (GPAS) is a unique opportunity to inform, discuss, and exchange knowledge on strategies to increase equitable access to care and treatment for the global bleeding disorders community. We look forward to connecting with you virtually this July!

Also available in: English Français Español

Join us online at #MSKCongress

Global Policy and Access Summit

[email protected]

AGENDA

This two-day virtual event will feature plenary and educational sessions, slam sessions with advocacy cases and key stakeholder discussions*—all focusing on topics related to advancing care and access to treatment around the globe.

All session times are listed in EDT.

*Key stakeholder discussions are by invitation only.

Calendar









08:30 – 09:00
OPENING PLENARY: Towards equitable access

Join the opening plenary to hear about the GPAS objectives and the program highlights. Learn more about the WFH’s work in areas of improving equitable access to diagnosis, treatment and care for people with bleeding disorders, regardless of their bleeding disorder, gender and where they live.

Chair
Salome Mekhuzla, Director – Global Development, World Federation of Hemophilia, Montreal, Canada

Opening remarks – Towards equitable access for all
Cesar Garrido, President, World Federation of Hemophilia, Caracas, Venezuela

Keynote address
Clive Ondari, Director of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland

09:00 – 10:00
EDUCATIONAL SESSION: Disparities in access to diagnosis and care: A global snapshot

Access to diagnosis and care varies widely from country to country, region to region. Join our experts as they highlight global disparities in identification and diagnosis, access to therapies, access to prophylaxis, and more, with a special focus on the barriers faced by people with hemophilia, von Willebrand’s disease and women and girls with bleeding disorders.

Chair
Rana Saifi, Regional Manager, Eastern Mediterranean, World Federation of Hemophilia, Montreal, Canada

Global disparities in access to diagnosis and care for PWBD
Alain Baumann, CEO, World Federation of Hemophilia, Montreal, Canada

Barriers in accessing diagnosis and care for people with VWD
Nathan Connell, Chief of Medicine, Brigham and Women’s Faulkner Hospital, Boston, United States

Barriers in accessing diagnosis and care for women and girls with bleeding disorders
Dawn Rotellini, Chief Operating Officer, National Hemophilia Foundation, Gibsonia, United States

10:00 – 10:15
BREAK
10 :15 – 11:15
LIGHTNING ROUND SESSION: Around the world in 60 minutes: What has worked well in advocacy initiatives and what are the lessons learned

Our National Member Organizations around the world are on the frontlines of advocacy for people with bleeding disorders. Join this session and hear more from our NMOs on some of the leading advocacy projects taking place in their countries to address the barriers in diagnosis and care. Get inspired as our featured presenters share their experience, lessons learned, and actionable recommendations you can implement today.

Chair
Juan Andrés Pereira de Souza, President, Asociación De Hemofilia Del Uruguay, Montevideo, Uruguay

Advocating for the setting up of a prophylaxis network
Latifa Lamhene, Association Nationale des Hémophiles, Algeria

Path to prophylaxis in Egypt
Mohammed Soliman, Egyptian Society of Hemophilia, Egypt

Reduce the gap in diagnosis, treatment and care between women/girls and men/boys with BDs
Yannick Collé, Association Nationale des Hémophiles, France

Inclusion of haemophilia and other bleeding disorders patients into the National Council of a Persons with Diasbilities (NCPWD)
James Kago, Kenya Haemophilia Association, Kenya

Sudan: Sustaining access to care and treatment for patients with bleeding disorders during a fighting in April-May 2023
Nawal Eltayeb MD, Sudanese Hemophilia Society, Sudan

Advocating for a focus on women with bleeding disorders in Syria’s health care system
Tahani Ali MD, Syrian Hemophilia Society, Syria

All Copays Count Coalition
Bill Robie, National Hemophilia Foundation, United States

11 :15 – 12:15
EDUCATIONAL SESSION: Strategies to accelerate identification and diagnosis of PWBD: Diagnosis -First step to access care

The WFH estimates that over 70% of expected people living with hemophilia worldwide have not yet beenidentified and diagnosed. Join this session to discover key findings from the WFH NMO survey on barriers toidentification and diagnosis. Learn strategies to strengthen health care systems by looking at the role of primaryhealthcare, national screening programs, and recommendations from the WFH guidelines on hemophilia andVWD. Join the discussion as our panel of experts highlights successful outreach projects which have acceleratedidentification and diagnosis of PWBD.

Chair
Emna Gouider, Chief, Aziza Othmana Hospital- University Tunis El Mana, Tunis, Tunisia

Presentation of WFH NMO survey on barriers to identification and diagnosis
Juliana Hagembe, Outreach & Diagnosis Consultant, World Federation of Hemophilia, Nairobi, Kenya

Strengthening health systems to increase identification and diagnosis of PWBD
Adriana Velasquez Berumen, Team Lead Medical Devices and In Vitro Diagnostics, MDD, World Health Organization, Geneva, Switzerland

Panel discussion on strategies to accelerate identification and diagnosis of PWBD
Megan Adediran, Executive Director, Haemophilia Foundation of Nigeria, Kaduna, Nigeria
Mina (Kate) Hill, Haemophilia Nurse Co-Ordinator, South African Haemophilia Foundation, Cape Town, South Africa
Tahani Ali, Professor, Hematology & blood transfusion, Faculty of medicine, Damascus University, Damascus, Syria

12:15 – 12:30
BREAK
12 :30 – 13:30
STAKEHOLDER DISCUSSIONS: Towards equitable access

* By invitation only

07 :00 – 08 :00
STAKEHOLDER DISCUSSIONS: Towards equitable access

* By invitation only

08:30 – 09:30
EDUCATIONAL SESSION: Strengthening organization of care for bleeding disorders

How to ensure that patient organizations have a seat at the decision-making table? Join our keynote expert to uncover concrete strategies for successful advocacy to secure sustainable government investment for bleeding disorders. Learn about the multi-prong approach to strengthening care delivery systems by looking at WFH guidelines on national organization of care and recommendations on effective care delivery, national bleeding care programs and committees, and the vital role of the NMO in advancing the process. Learn about a captivating case study from Brazil which will cover the government perspective on developing national bleeding disorder programs.

Chair
Ekawat Suwantaroj, Vice President, Thai Hemophilia Patient Club – National Hemophilia Foundation of Thailand, Bangkok, Thailand

Strategies to increase government investment in bleeding disorders
Dawn Rotellini, Chief Operating Officer, National Hemophilia Foundation, Gibsonia, United States

Strengthening care delivery systems
Alok Srivastava, Professor, Christian Medical College, Vellore, India

Government perspective on national bleeding disorder programs and/or a country case on including bleeding disorders in health policies
Erich Vinicius de Paula, Ministry of Health, Brazil

09:30 – 10:30
EDUCATIONAL SESSION: Tackling inequities in access in an era oftherapeutic advances

Access to current therapies varies greatly around the world. The session will begin with an overview of currently available therapies and what’s coming down the pipeline. Following this, an expert panel discussion will address the challenges of increasing equitable access in the fast-changing treatment landscape. Join the conversation to learn more about developments in novel therapies and what strategies should be put in place to increase equitable access to existing and novel therapies.

Chair
Dawn Rotellini, Chief Operating Officer, National Hemophilia Foundation, Gibsonia, United States

Overview of existing and novel therapies in bleeding disorders
Len Valentino, CEO, National Hemophilia Foundation, New York, United States

Panel discussion on increasing equitable access in era of a fast-changing treatment landscape
Brian O’Mahony, CEO, Irish Haemophilia Society, Dublin, Ireland
Len Valentino, CEO, National Hemophilia Foundation, New York, United States
Cedric Hermans, Head, Hemophilia Center, Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium
David Page, Director of Health Policy, Canadian Hemophilia Society, Montreal, Canada

10:45 – 11:45
WFH HIGHLIGHT SESSION: Increasing equitable access: PACT program

Launched in 2021, the WFH Path to Access to Care and Treatment (PACT) Program is designed to improve outreach and diagnosis and increase access to sustainable care for PWBD. Where are we two years in? Discover the progress made since 2021 towards achieving the PACT program goals. Learn more about the PACT Advocacy Academy 8-month long course and hear real-life stories from NMOs engaged in the PACT program as they share their outcomes and the impact of their participation on the bleeding disorders community in their country.

Chair
Salome Mekhuzla, Director – Global Development, World Federation of Hemophilia, Montreal, Canada

PACT Program objectives and 2 year progress
Guada Lagrada, Head – Regional Development, World Federation of Hemophilia, Montreal, Canada

PACT Advocacy Academy
Julia Chadwick, Education Materials Coordinator , World Federation of Hemophilia, Montreal, Canada

Panel discussion: Impact stories from PACT countries
Juan Andrés Pereira de Souza, President, Asociación De Hemofilia Del Uruguay, Montevideo, Uruguay
Flerida Hernandez, Physician, Hemophilia Association of the Philippines for Love and Service Inc., Manila,Philippines
Premroop Alva, President, Hemophilia Federation (India), New Delhi, India
Abdoulaye Loum, President, Association Sénégalaise des Hémophiles (ASH), Dakar, Senegal

11 :45 – 12:45
EDUCATIONAL SESSION: Shared decision-making model in health care

Learn about the SDM model and its value in enabling PWH to make informed treatment decisions alongside their healthcare team. Discover concrete examples of its successful application in other types of disease. Witness the global debut of the new WFH Shared Decision-Making tool for hemophilia. Learn
how the the SDM model can be applied in clinical practice.

Chair
Courtney Thornburg, Medical Director, Hemophilia and Thrombosis Treatment Center at Rady Children’s Hospital, San Diego, United States

Presentation on shared decision-making model in healthcare and its value
Mark Skinner, President and CEO, Institute for Policy Advancement Ltd, Washington, United States

WFH shared decision-making tool
Donna Coffin, Director, Research & Education, World Federation of Hemophilia, Montreal, Canada

pplying the shared decision-making model in clinical practice
Victor Jiménez-Yuste, Head of department, Hospital La Paz, Madrid, Spain

Applying the shared decision-making model as a patient
Bradley Rayner, Head of Programmes, South African Haemophilia Foundation, Cape Town, South Africa

12:45 – 13:00
CLOSING PLENARY

Alain Baumann, CEO, World Federation of Hemophilia, Montreal, Canada
Salome Mekhuzla, Director – Global Development, World Federation of Hemophilia, Montreal, Canada

By invitation only
Simultaneous interpretation available in Spanish, French, Russian & Arabic
Program is subject to change

SPONSORS

The third edition of the WFH Global Policy and Access Summit (GPAS) is supported by funding from the Hemophilia Alliance and its member hemophilia treatment centres (HTCs) across the U.S.A.

SILVER SPONSORS

COMMITTEE & SPEAKERS

Meet the members of the WFH Global Policy and Advocacy Group who are overseeing the development of the GPAS 2023 Program:  

President
Association Sénégalaise des Hémophiles (ASH)
Dakar, Senegal

Team Lead Medical Devices and In Vitro Diagnostics, MDD,
World Health Organization,
Geneva, Switzerland

CEO – Chief Executive Officer
Federación Mundial de Hemofilia,
Montreal, Canadá

Professor

Christian Medical College

India

Director, State Government Relations
National Hemophilia Foundation
United States

Head of Programmes
South African Haemophilia Foundation
South Africa

CEO
Irish Haemophilia Society
Dublin, Ireland

Head, Hemophilia Center
Cliniques Universitaires Saint-Luc
Germany

President World Federation of Hemophilia
Caracas, Venezuela

Director of Health Products Policy and Standards,
World Health Organization,
Geneva, Switzerland

Medical Director

Hemophilia and Thrombosis Treatment Center at Rady Children’s Hospital-San Diego

United States

David Page
Director of Health Policy
The Canadian Hemophilia Society (CHS)

Chief Operating Officer
National Bleeding Disorders Foundation
Gibsonia, United States

Director, Research & Education
World Federation of Hemophilia
Canada

Vice President of the Thai Hemophilia Patient Club
Thai Hemophilia Society
Bangkok, Thailand

Chief
Biological Hematology Department,
Aziza Othmana Hospital- University Tunis El Mana,
Tunis, Tunisia

Medical Consultant of the National Program for Hereditary Bleeding Disorders
Ministry of Health in Brazil
Brazil

Physician
Hemophilia Philippines (HAPLOS Community) Foundation, Inc.
Manila, Philippines

Head, Regional Development
World Federation of Hemophilia
Montreal, QC

Haemophilia A
board Member of Kenya Haemophilia Association
Kenya

President
Asociación De Hemofilia Del Uruguay
Montevideo, Uruguay

Education Materials Coordinator,
World Federation of Hemophilia
Canada

Outreach & Diagnosis Consultant,
World Federation of Hemophilia,
Nairobi, Kenya

Member, Association Nationale des Hémophiles, Algeria

CEO
National Hemophilia Foundation
United States

President and CEO
Institute for Policy Advancement Ltd
United States

Lay Member, Board of Directors
World Federation of Hemophilia
Zagreb, Croatia

Executive Director
Haemophilia Foundation of Nigeria
Kaduna, Nigeria

Haemophilia Nurse Co-Ordinator
South African Haemophilia Foundation
South Africa

Member
Egyptian Society of Hemophilia
Egypt

Assistant Professor of Medicine
Brigham and Women’s Faulkner Hospital
Boston, United States

Member
Sudanese Hemophilia Care Association
Sudan

President,
Hemophilia Federation (India),
India

Regional Manager, Eastern Mediterranean,
World Federation of Hemophilia,
Montreal, Canada

Director Global Development
World Federation of Hemophilia
Montreal, Canada

Professor, M.D.
Hematology & blood transfusion, Faculty of medicine, Damascus University
Syria

Associate Professor
Universidad Autónoma de Madrid
Spain

Co-Leader
French NMO WBD Committee
Six-Fours-les-Plages, France

REGISTRATION INFORMATION

Register now for this free virtual-only event! Registration grants you access to all sessions on July 6 and 7, 2023, except for stakeholder discussions, which are by invitation only.

Please contact [email protected] for more registration information.

The WFH can offer events like GPAS for free thanks to the support given to us by our generous donors. By donating to the WFH you will be supporting national and global advocacy efforts, so that all people with bleeding disorders are given a voice. Your support is vital—please consider donating today at give.wfh.org

RELEVANT RESOURCES

Interested in catching up on the discussions from GPAS 2021 and 2022? View recordings of select sessions on the WFH eLearning platform.

TRAVEL

FAQ

Please contact [email protected] for more information.

QWho would benefit from attending GPAS?
A
  • WFH NMO leaders and advocates
  • Healthcare professionals
  • National governments
  • Other organizations representing the interests of people with bleeding disorders
  • Regional and global government agencies (such as the WHO, etc.) and partner organizations
  • Industry representatives
  • Researchers and any individuals with interest in the field of bleeding disorders
QWill recordings be made available after the event?
AAll sessions will be available on demand for 60 days, until August 31, 2023. You can access them on this same event platform. Session recordings in English will appear within 24 hours. All other languages will be available few weeks after the end of the event.
QWill there be any live interpretation?
AThe event will feature live interpretation in Spanish, French, Arabic and Russian.
QWhen will I receive my login information to access the virtual event?
ALogin information will be sent to all registered attendees on July 4, 2023

EVENT NEWS

< PREV NEXT >

SEARCH

Also available in: Français Español

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.

Share on:

Relevant resources

Resources from the Global Policy and access summit 2021

Other Resources

Hemophilia Alliance

Recognizing that training women leaders ensures the diversity our community need to thrive; the Hemophilia Alliance has been a longtime supporter of the Susan Skinner Memorial Fund. They deepened their engagement with the global community through the establishment of the Travel Grant Program, which allows US-based multidisciplinary healthcare professionals the opportunity to attend WFH global training workshops. The wealth of experience and perspective attendees bring back home to their communities helps patients across the country. Their patience and support as we grappled with changing norms in these challenging times gave us the flexibility to meet our community’s needs with revamped programming.

Israel - Tel Hashomer

Year of IHTC designation: 1993

National Hemophilia Center, Tel Hashomer
Sheba Medical Center

Areas of Specialty

  • Adult and pediatric hematology
  • Orthopedic surgery
  • Nursing
  • Physiotherapy
  • Dental care
  • Laboratory diagnosis (not genetics)
  • Psychology

South Africa - Johannesburg

Year of IHTC designation: 2016

Haemophilia Comprehensive Care Centre
Charlotte Maxeke Johannesburg Academic Hospital

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis and hemostasis
  • Physiotherapy

Singapore - Singapore

Year of IHTC designation: 2002

Singapore General Hospital Haemophilia Treatment Clinic

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis
  • Nursing
  • Dental care
  • Orthopedic care (no surgeries)
  • Physiotherapy
  • Psychology

Senegal - Dakar

Year of IHTC designation: 2016

Centre International de Traitement de l’Hémophilie (CITH) de Dakar
Centre National de Transfusion Sanguin (CNTS)

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Blood banking
  • Physiotherapy

Russia - Moscow and St. Petersburg

Year of IHTC designation: 2010

National Medical Research Center of Hematology of the Russian Academy of Medical Sciences

Areas of Specialty

  • Adult hematology
  • Nursing
  • Orthopedic surgery

Netherlands - Utrecht

Year of IHTC designation: 1996

Van Creveldkliniek
University Medical Centre Utrecht

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hematology
  • Nursing
  • Orthopedic care and surgery
  • Physiotherapy/Occupational therapy

Japan - Nara

Year of IHTC designation: 1998

Nara Hemophilia Centre
Nara Medical University

Areas of Specialty

  • Adult and pediatric hematology
  • Orthopedic care and surgery
  • Laboratory diagnosis and Molecular genetics
  • Physiotherapy

Italy - Milan

Year of IHTC designation: 1972

Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics
  • Dental care
  • Blood banking
  • Orthopedic care and surgery
  • Physiotherapy
  • Diagnostic assessment of platelet functional defects

India - Mumbai

Year of IHTC designation: 2000

National Institute of Immunohaematology (ICMR) and KEM Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics
  • Dental care
  • Orthopedic care
  • Physiotherapy

India - Vellore

Year of IHTC designation: 2000

Christian Medical College, Vellore

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics with antenatal diagnosis
  • Nursing
  • Musculoskeletal management – physical and occupational therapy with physiatry
  • Orthopedic care and surgery
  • Blood banking
  • Dental care
  • Psychology/Social services
  • Antenatal diagnosis

Sweden - Malmö

Year of IHTC designation: 1976

Malmö Centre for Thrombosis and Haemostasis
Department for Hematology and Coagulation Disorders, Skåne University Hospital
Skåne University Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and genetics
  • Nursing
  • Dental care and surgery
  • Orthopedic care and surgery
  • Blood banking (on request)

France - Paris

Year of IHTC designation: 1972

Paris Haemophilia Centre (Necker (N) and Kremlin Bicetre (KB) Hospitals)

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Dental care
  • Orthopedic care and surgery
  • Psychology and Social services

Egypt - Cairo

Year of IHTC designation: 2015

Shabrawishi Hospital, Egyptian Society of Hemophilia, and Cairo University

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Molecular genetics
  • Blood banking
  • Physiotherapy

Canada - Toronto

Year of IHTC designation: 2018

University of Toronto Hemophilia Centres
St. Michael’s Hospital

Areas of Specialty

  • Adult hematology services
  • Pediatric hematology services
  • Physiotherapy/occupational therapy
  • Dental care
  • Orthopaedic care (no surgery)
  • Laboratory diagnosis
  • Nursing
  • Psychology/social services

Brazil - Campinas, SP

Year of IHTC designation: 2008

Hemocentro – “Unidade de Hemofilia Cláudio Luiz Pizzigatti Corrêa”
Hemocentro Unicamp, University of Campinas

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and molecular genetics
  • Nursing
  • Dentistry
  • Physiotherapy

Belgium - Brussels

Year of IHTC designation: 2013

Haemostasis and Thrombosis Unit
Division of Haematology
Cliniques universitaires Saint-Luc

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis
  • Orthopedic care and surgery

Belgium - Leuven

Year of IHTC designation: 1972

Hemofiliecentrum Leuven, University of Leuven

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis (not genetics)
  • Nursing
  • Psychology
  • Social services
  • Orthopedic care and surgery

Austria - Vienna

Year of IHTC designation: 1972

Medical University of Vienna
Department of Medicine I
Clinical Division of Hematology and Hemostaseology

Areas of Specialty

  • Adult hematology

Australia - Melbourne

Year of IHTC designation: 2005

Ronald Sawers Haemophilia Centre

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis and hemostasis
  • Orthopedic care and surgery
  • Nursing
  • Dental care
  • Blood banking
  • Psychology
  • Social work

Argentina - Buenos Aires

Year of IHTC designation: 1974

Instituto Asistencial “Dr. Alfredo Pavlovsky”
(Fundación de la Hemofilia)

Instituto De Investigaciones Hematológicas “Dr. Mariano R. Castex” (IIHEMA
(Academia Nacional de Medicina)

Areas of Specialty

  • Adult and pediatric hematology
  • Physiotherapy
  • Dental care
  • Orthopaedic care and surgery
  • Laboratory diagnosis and genetic diagnosis
  • Nursing
  • Psychology
  • Social services

Spain - Madrid

Year of IHTC designation: 2018

Hospital Universitario La Paz

Areas of Specialty

  • Adult and pediatric hematology
  • Physiotherapy/occupational therapy
  • Dental care
  • Orthopaedic care (no surgery)
  • Laboratory diagnosis
  • Nursing
  • Psychology/social services

Spain - Valencia

Year of IHTC designation: 1997

Haemostasis and Thrombosis Unit
Haematology Service, University and Polytechnic Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics
  • Nursing
  • Orthopedic care and surgery
  • Physiotherapy
  • Blood banking
  • Psychology and Social services

Thailand - Bangkok

Year of IHTC designation: 1984

International Hemophilia Training Center – Bangkok
Ramathibodi Hospital
Mahidol University

Areas of Specialty

  • Adult and pediatric hemostasis
  • Molecular genetics
  • Nursing
  • Dental care and surgery
  • Orthopedic care and surgery
  • Physiotherapy
  • Blood banking
  • Psychology and social services

Hemophilia of Georgia

Hemophilia of Georgia has stood with us for over three decades, playing an early role in distributing donated factor via the WFH Humanitarian Aid program. Our relationship has deepened over the years as they continued to support this program and came on board as a founding Chapter Challenge champion in 2016. Their belief in educating future leaders is clear in their investment in the Youth Leadership Workshops, which has led to the training of over 50 young adults. They also support workshops devoted to educating providers and patient leaders on how to collect and use data to advocate for better patient care. Their staff generously volunteer their time as trainers and as well as serving on various committees.

WFH President's Award - Recipients

National Bleeding Disorders Foundation

The National Bleeding Disorders Foundation helps advance our mission on several fronts. They inspire others to follow their lead as a founding champion of the NHF Chapter Challenge. Their commitment to equality of access is demonstrated in their support of the Cornerstone Initiative, which lays the foundation for care in the world's most underserved regions, as well as programs that aim to raise awareness and improve care of women with bleeding disorders and those with von Willebrand disease. We also benefit from their steadfast engagement with various programs including the WFH Twinning Program and their individual leaders’ contribution to our leadership and committees.

Legacy Gift

Do you sometimes wish you could do more? A bequest is a simple way for you to make a significant gift without changing anything about your financial security and lifestyle today. Your legacy will sustain care for the generations to come.

Download these sample clauses to give to your legal advisor.

We understand if you prefer to remain anonymous, but we would be very honoured if you would let us know of your intentions so that we may thank you personally. We would also be happy to answer any questions you may have or give you additional information. Please contact Jennifer Laliberté at 514‑875‑7944 ext.2822 or [email protected].

Disclaimer

The information on the WFH USA website is provided for general information purposes only. The WFH USA does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH USA recommends that you contact your physician or local treatment centre. Before administering any products, the WFH USA urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH USA does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH USA discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH USA social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH USA recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH USA. The WFH USA is not responsible and assumes no liability for the content of any linked websites.

Website privacy policy

The WFH USA does not collect personally identifying information about you when you visit our site, unless you choose to provide such information to us. Providing such information is strictly voluntary. This policy is your guide to how we will handle information we learn about you from your visit to our website.

Use of links

Throughout our website, we provide links to other servers which may contain information of interest to our readers. We take no responsibility for, and exercise no control over, the organizations, views, or accuracy of the information contained on other servers. When linking to the WFH USA, we request that you ensure that there are no associated connections for commercial purposes. Any official use of the name WFH USA or the use of its logo needs to be approved by the WFH USA. If you have a link you’d like us to consider adding to our website, please send an email to [email protected] with the subject “Link request.”

Use of text and images

All information, photographs, graphics, and other material on this website are protected by copyright. While users of this website may use the content for personal, non-commercial use, none of the content of this website can be modified, translated, transferred or sold, copied, reproduced, published, or distributed, in whole or in part, without the prior written consent of the WFH USA. To view a copy of the WFH USA’s permissions guidelines, click here.

The WFH USA encourages the dissemination of its information and welcomes proposals on the reprinting, redistribution, and translation of its materials. If you would like to publish information that you find on our website, please send your request to [email protected].

Accessibility

If you have suggestions on how to make the site more accessible, please contact us at [email protected].

Opt-Out or Change Your Contact Information

Our website provides users the opportunity to opt-out of receiving communications from us through a special online form or via the communication they have received. You may, at all times, choose to receive which communications within the organization you can receive or none at all. You may also update your contact information previously provided to us via another online form.

Questions about our policies

If you have any questions about this privacy statement, the practices of this site, or your dealings with this website, you can contact us at [email protected].

Fraud alert

Unauthorized solicitations – Warning

The WFH USA has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH USA staff or falsely stating that they are associated with the WFH USA. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH USA, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH USA emails come from @wfhusa.org or @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH USA at [email protected] or call 1-877-417-7944.

International Award for Outstanding Service - Recipients

International Lifetime Achievement Award - Recipients

Previous years

2012Christine Lee
United Kingdom
2006Dr. Bruce Evatt
United States

International Healthcare Volunteer Award - Recipients

Previous years

2012 Piet de Kleijn
The Netherlands
2010 Dr. Mammen Chandy
India
2008 Dr. Man-Chiu Poon
Canada
2006 Dr. Norma de Bosch
Venezuela
2004 Dr. Parttraporn Insarangkura
Thailand

Dr. Carol K. Kasper
United States

United Kingdom - London

Year of IHTC designation: 1970

Katharine Dormandy Haemophilia Centre and Thrombosis Unit
Royal Free Hospital

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Orthopedic care and surgery
  • Physiotherapy/Occupational therapy
  • Molecular genetics
  • Psychology/Social services

United Kingdom - Manchester

Year of IHTC designation: 2008

Manchester Haemophilia Comprehensive Care Centre (Children’s and Adult’s)
Manchester Royal Infirmary and Manchester Children’s Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Orthopedic care and surgery
  • Nursing
  • Molecular genetics
  • National Hemophilia database

United Kingdom - Oxford

Year of IHTC designation: 1972

Oxford Haemophilia Centre and Thrombosis Centre
Churchill Hospital

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Orthopedic care and surgery
  • Nursing
  • Molecular genetics
  • Physiotherapy/Occupational therapy

United Kingdom - Sheffield

Year of IHTC designation: 1992

Sheffield Haemophilia and Thrombosis Centre
Royal Hallamshire Hospital

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis and hemostasis
  • Molecular genetics

Twins of the Year Awards

2020 Aluva (India) – Newcastle (UK)
2019 Yogyakarta / Solo (Indonesia) – Utrecht (Netherlands)
2018 Abidjan (Ivory Coast) – Brussels (Belgium)
2017 Santa Cruz de la Sierra (Bolivia) – Buenos Aires (Argentina)
2016 Kampala (Uganda) – London (UK)
2015 Varna (Bulgaria) – Bonn (Germany)
2014 Arequipa (Peru) – Los Angeles (USA)
2013 Davangere (India) – Liverpool (UK)
Ludhiana (India) – Detroit (USA)
2012 Hanoi (Vietnam) – Melbourne (Australia)
2011 Manado (Indonesia) – Utrecht (Netherlands)
2010 Delhi (India) – Winnipeg (Canada)
Yaoundé (Cameroon) – Geneva (Switzerland)
2009 Chisinau (Moldova) – Warsaw (Poland)
Colombo (Sri Lanka) – Vellore (India)
2008 Gaborone (Botswana) – Philadelphia (USA)
2007 Vientiane (Laos) – Brest (France)
Damascus (Syria) – Montpellier (France)
2006 Lima (Peru) – Fort Worth (USA)
2005 Yerevan (Armenia) – Minneapolis (USA)
Casablanca (Morocco) – Caen (France)
2004 Beirut (Lebanon) – Geneva (Switzerland)
Santo Domingo (Dominican Republic) – Caracas (Venezuela)
2003 Cairo (Egypt) – Knoxville (USA)
2002 Moscow (Russia) – Liverpool (UK)
Panama – Valencia (Spain)
2001 Bangalore (India) – St. Louis (USA)
2000 Pune (India) – Bradford (UK)
1999 Montevideo (Uruguay) – Buenos Aires (Argentina)
Tianjin (China) – Calgary (Canada)
1998 Plovdiv (Bulgaria) – Bonn (Germany)
1997 Bogota (Colombia) – Los Angeles (USA)
Tartu (Estonia) – Stockholm (Sweden)
1996 Timisoara (Romania) – Munich (Germany)
Riga (Latvia) – Munster (Germany)
1995 Klaipeda (Lithuania) – Malmo (Sweden)
1994 Bratislava (Slovakia) – Tel Hashomer (Israel)

Pietrogrande Prize

2021 Axel Seuser
Germany
2019 Dr. Adolfo Llinás
Colombia
2017 Pamela Hilliard
Canada
2015 Kathy Mulder
Canada
2013 James Luck
United States
2012 Piet de Kleijn
The Netherlands
2011 Dr. Lily Heijnen
The Netherlands
2010 Dr. Horacio Caviglia
Argentina
2009 Jerome D. Wiedel
United States
2008 Dr. Federico Fernández-Palazzi
Venezuela
2007 Michael Heim
Israel
2006 Brenda Buzzard
United Kingdom
2005 Dr. Marvin Gilbert
United States

Henri Horoszowski Award

2021 Baolai Hua
Yangzhou College, Xuzhou Medical University
The effects of intra-articular injection of TNF-alpha Antagonists in treatment of haemophilic synovitis
2019 Maarten Eerdekens
Belgium
Association between multi-segment foot kinetics and blood induced joint damage in adult patients with hemophilic ankle arthropathy
2017 Fabio Souza
Brazil
Decrease in joint inflammation, swelling and pain after a swimming protocol in animal model of experimental-induced hemarthrosis
2015 SM Javd Mortazavi
Iran
Bilateral total knee arthroplasty in patients with hemophilia: A safe and cost-effective procedure
2013 Lize F.D. van Vulpen
United States
A fusion protein of IL4 and IL10, is equally effective in protecting cartilage from blood-induced damage compared to the individual components
2012 Horacio Caviglia
Argentina
Pseudotumor Surgery in Haemophilia A patients: Comparitive results between inhibitor and non-inhibitor patients
2011 Nick Goddard
United Kingdom and
Monique van Meegeren
The Netherlands
Early onset administration of IL-4 and IL-10 prevents blood-induced cartilage damage in vitro
2010 Lydia Abad-Franch
Spain
Influence of an Aquatic Training Protocol on the Reduced Risk of Cardiovascular Morbidity and Mortality in a Hemophiliac
2009 Sebastien Lobet
Belgium
Impact of Hemophilia Ankle Arthropathy on Gait Disability: Analysis of Energetic and Mechanical Variables
2008 Jose Alberto Tlacuilo-Parra
Mexico
Bone Turnover Markers and Bone Mineral Density in Children with Hemophilia
2007 Natalie Jansen
The Netherlands
Protective Abilities of Interleukin-10 in Blood-induced Cartilage Damage
2006 Axel Seuser and E. Kusch
Germany
Multi-Center Study of Orthopedic Outcome of the Lower Extremities in 249 Children with Hemophilia
2005 Frank van Genderen, Nico van Meeteren, Lily Heijnen, Piet de Kleijn, Marijke van den Berg, Paul Helders
The Netherlands
The Hemophilia Activities List: Final development and validation of a hemophilic-specific self-assessment questionnaire on functional abilities
2004 Goris Roosendaal, Zalima N Jahangier, Kim MG Jacobs, Johannes WJ Bijlsma, Floris PJG Lafeber
The Netherlands
Radiosynoviorthesis using YTTRIUM-90 results in adverse direct effects on cartilage: a human in vitro study
2003 Axel Seuser, Thomas Wallny, Günter Schumpe, Elmar Trunz, Hans-Hermann Brackman
Germany
How to advise young haemophiliacs to find the right sport? A new and safe algorithm
2002 James Luck, Jr. and Mauricio Silva
United States
Long-Term Review of Total Knee Arthroplasty
2001 Federico Fernández-Palazzi
Venezuela
Oxytetracycline Chlorohydrate: A new material for chemical synovial orthoses
2000 Horacio Caviglia
Argentina
Pseudotumours
1999 William J. Ribbans and J.L. Hicks
United Kingdom
Communication and Co-operation for the New Millennium – The Future of the Musculoskeletal Committee in the 21st Century
1998 Adolfo Llinas, Mauricio Silva, Monica Duarte, Gonzalo Ucros, Graciela Perini, Angela Maria Cerquera, Andres Forero
Colombia
Chromic phosphate synoviorthesis without age restriction should be the first treatment option for chronic active hemophilic synovitis

International Frank Schnabel Volunteer Award - Recipients

Previous years

2012Martha Patricia Monteros Rincon
Mexico
2010Antonia Luque de Garrido
Venezuela
2008Jean Michel Bouchez
France
2006Yuri Zhulyov
Russia
2004Ashok Verma
India

Quality of life scale

The outcomes of interest collected in the WBDR include demographic characteristics, clinical and treatment-related outcomes, burden of disease outcomes, and quality of life. The quality of life scale, EQ-5D-5L, is part of the WBDR extended data set. It is available in more than 130 languages and in different modes of administration.

If you would like a different language, please email us at [email protected].

Other available languages include

Amharic
Arabic (Algeria, Morocco, UAE)
English (Ghana, India, Jamaica, Kenya, Nigeria, and the Philippines)
French (Algeria, Belgium, and Morocco)
Hungarian
Malayalam
Nepali
Punjabi
Russian (Ukraine)

Serbian
Spanish (Argentina, Panama, Spain, and the U.S.A)
Swahili
Tagalog
Thai
Twi
Ukrainian
Urdu
Vietnamese

For more information, please visit: euroqol.org/eq-5d-instruments/eq-5d-5l-about.

Functional Scales

The outcomes of interest collected by the WBDR include demographic characteristics, clinical and treatment-related outcomes, burden of disease outcomes, and patient-reported outcomes.

The WBDR includes five functional scales as part of its extended data set:

WBDR hemophilia data sets

WBDR Minimal Data Set

The WBDR Minimal Data Set (MDS) is a set of data on demographics, diagnosis, symptoms and treatment which are collected on patients participating in the WBDR.

WBDR Extended Data Set

The WBDR Extended Data Set (EDS) is a larger set of data, with more details than the MDS, which includes questions on patient demographics, diagnosis, symptoms, treatment and burden of disease. The EDS can be used by hemophilia treatment centers to collect data on patients participating in the WBDR. The WBDR Extended Data Set (EDS), was added to the database in March 2019.

United States - Chapel Hill, North Carolina

Year of IHTC designation: 1972

University of North Carolina Hemophilia & Thrombosis Center

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis
  • Nursing
  • Physiotherapy/ Occupational therapy
  • Psychology/ Social services

United States - Columbus, Ohio

Year of IHTC designation: 2018

Nationwide Children’s Hospital

Areas of Specialty

  • Pediatric hematology services
  • Physiotherapy/occupational therapy
  • Dental care
  • Orthopaedic care (no surgery)
  • Laboratory diagnosis
  • Nursing
  • Psychology/social services

United States - Houston, Texas

Year of IHTC designation: 2000

Gulf States Hemophilia and Thrombophilia Center
University of Texas Health Science Center at Houston

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Blood banking
  • Physiotherapy/ Occupational therapy
  • Psychology/Social services

United States - Los Angeles, California

Year of IHTC designation: 1970

Orthopaedic Hemophilia Treatment Center

Areas of Specialty

  • Adult hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Orthopedic care and surgery
  • Physical therapy
  • Psychology/Social services

United States - New York, New York

Year of IHTC designation: 1993

Mount Sinai School of Medicine
Mount Sinai Medical Center

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Orthopedic care and surgery
  • Molecular genetics
  • Social services

United States - Rochester, Minnesota

Year of IHTC designation: 1974

Mayo (Rochester) Comprehensive Hemophilia Center, and International Hemophilia Training Center (WFH)
Mayo Clinic/Foundation and Mayo Medical School

Areas of Specialty

  • Adult and pediatric hematology
  • Laboratory diagnosis and hemostasis
  • Nursing
  • Orthopedic care and surgery
  • Blood banking
  • Molecular genetics
  • Psychology/ Social services

United States - San Diego, California

Year of IHTC designation: 2018

Hemophilia & Thrombosis Treatment Center
University of California San Diego

Areas of Specialty

  • Adult hematology
  • Physiotherapy/occupational therapy
  • Dental care
  • Orthopaedic care (no surgery)
  • Laboratory diagnosis
  • Nursing
  • Psychology/social services

Our history

The WFH was established in 1963 by Frank Schnabel, a Canadian businessman born with severe hemophilia A. He believed that patient organizations could be much more effective—and do more to represent the interests of people living with bleeding disorders—if they worked together. The first WFH Congress was held in Copenhagen, Denmark, on June 25, 1963, and was attended by representatives from 12 countries. Now, the WFH and our global network of national member organizations (NMOs) represent the interests of people with hemophilia and other inherited bleeding disorders in 147 nations.